Live
- Apple Unveils OpenELM AI Models for On-Device Tasks: Details
- Actress Sahithi Dasari steps into politics, contesting as an independent candidate from Chevella Constituency
- Vijayawada: 58 nominations filed in NTR district
- Prabhas Donates Rs 35 Lakh to Support Telugu Film Directors Association
- Rashmika Mandanna Joins Dhanush and Nagarjuna in the Shoot for 'Kubera’
- Alliance Victory in Tanuku Constituency Marks Turning Point for Development," TDP
- YSRCP Minister Viddala Rajini Promises Development in Guntur West
- Mahesh Babu’s AMB Cinemas set to open in Bangalore
- YSRCP MP candidate Vijayasai Reddy assures protection of Muslim interests
- Vishwak Sen completes dubbing for ‘Gangs of Godavari’ teaser
Natco Pharma launches Hepatitis B medicine
Highlights
Natco Pharma has launched a generic version of Tenofovir Alafenamide, a drug used for treating chronic Hepatitis B. The company in a communique to BSE, said that it’s one of the first entities to launch the generic version of the drug under its brand Tafnat.
Hyderabad: Natco Pharma has launched a generic version of Tenofovir Alafenamide, a drug used for treating chronic Hepatitis B. The company in a communique to BSE, said that it’s one of the first entities to launch the generic version of the drug under its brand Tafnat.
Natco is producing Tafnat under license from Medicines Patent Pool (MPP) and Gilead Sciences. The company has priced the medicine at Rs1,900 for a monthly pack of 30 tablets for the Indian market. Natco Pharma’s stock closed 1.3 per cent lower at Rs 1,007.35 on BSE.
Next Story
ADVERTISEMENT
